Pharmafile Logo

New faces at Lucid, 90Ten and Page & Page

The latest movers in med comms

Lucid Group appoints new director

Rob Apollo

Lucid Group has appointed Rob Apollo as its new Director of Corporate Development.

Apollo is no stranger to the agency, having served on its board for the past 18 months representing LDC, who made a minority investment in Lucid back in June 2017.

He said: “I have seen the business continue to deliver best-in-class services to clients while maintaining market-leading organic growth. However, what really inspires me is Lucid’s purpose to help improve patients’ lives, which is at the heart of everything we do. I’m incredibly excited about what we’re going to achieve going forward. Let’s bring the magic.”

Apollo’s expertise is in acquiring and integrating businesses, and also in supporting growing businesses and building infrastructure.

The new appointment falls in line with Lucid’s wider growth strategy to acquire new capabilities, partnerships and companies.

90Ten bolsters its team

90Ten has added four new members to its public relations and medical education divisions.

Ruth McIntyre joins 90Ten Communications from Galliard, where she delivered patients education and corporate change management initiatives.

At 90Ten, McIntyre will become a senior account director, providing senior counsel to a number of the consultancy’s international accounts.

Also bolstering the 90Ten Communications team is Rob Jones, who joins the team as an account director.

Most recently Jones worked at the University of Brighton’s cardiac rehabilitation programme.

Jack Dixey, who was previously at Burson RX, also joins the team a senior account manager.

Meanwhile at 90Ten Medical, Niamh Mangan becomes a senior account director.

She was most recently at Cello Health Communications, bringing seven years of experience in medical education.

Clare Bates joins Page and Page

Clare Bates

Page and Page has poached Synergy Medical Communications’ Clare Bates, who joins the healthcare communications agency as its new editorial director.

Bates has 17 years’ experience developing content for pharmaceutical and medical device industries.

At Synergy, Bates was project director, working in rare diseases. She was also a publisher at Wounds UK and Wounds international, heading up the medical education division.

Lucid adds to writing and account teams

Lucid Group has bolstered its writing and account teams, appointing three new members.

Elaine Downey joins Vivid – Lucid’s rare and specialist diseases agency – as a senior account manager.

Downey has 15 years’ medical communications experience, with expertise in several therapy areas, including MS and pulmonary hypertension.

She said: “I am delighted to join the team at the start of such an exciting year. I’m looking forward to being part of such a pioneering business where everything really is about improving patient outcomes.”

Meanwhile, Caitlin Crook joins Lucid’s strategic consultancy Leading Edge as a senior account manager. Crook, who has over 12 years’ experience in medical communications, has in-depth knowledge of oncology and diabetes.

Joining Lucid Partners as a senior medical writer is Sarah Robinson, who will be based in Lucid’s London office.

Robinson has over 4 years’ experience in editorial and medical writing, with specialities in addiction medication and cystic fibrosis.

17th January 2019
From: Marketing
Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links